- Madrigal Pharmaceuticals (NASDAQ:MDGL) initiated with Buy rating and $191 (74% upside) price target at Goldman Sachs.
- Dova Pharmaceuticals (NASDAQ:DOVA) initiated with Neutral rating and $29 (flat) price target at Evercore ISI.
- LabCorp (NYSE:LH) initiated with Buy rating and $202 (22% upside) price target at Argus Research.
- HCA Healthcare (NYSE:HCA) and Tenet Healthcare resumed with Buy ratings at Mizuho Securities. LifePoint Health (NASDAQ:LPNT) and Community Health Systems (NYSE:CYH) resumed with Neutral ratings.
- Dexcom (NASDAQ:DXCM) upgraded to Outperform at Robert W. Baird.
- Sanofi (NASDAQ:SNY) upgraded to Buy at Liberum.
- Zimmer Biomet Holdings (NYSE:ZBH) downgraded to Neutral at Baird.
- Dicerna Pharmaceuticals (NASDAQ:DRNA) downgraded to Neutral with a $12 (flat) price target at H.C. Wainwright.
- Jazz Pharmaceuticals (NASDAQ:JAZZ) price target raised to $160 (6% upside) from $150 at H.C. Wainwright. Neutral rating maintained.
Premarket analyst action - healthcare
Recommended For You
About MDGL Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MDGL | - | - |
Madrigal Pharmaceuticals, Inc. |